Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

RNA-binding proteins, multifaceted translational regulators in cancer

(2015) Laurence Wurth et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

RNA-binding protein HuR promotes growth of small intestinal mucosa by activating the Wnt signaling pathway

(2014) Lan Liu et al.   MOLECULAR BIOLOGY OF THE CELL

Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer

(2013) Joachim Weischenfeldt et al.   CANCER CELL

CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer

(2013) L. Burkhardt et al.   CANCER RESEARCH

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressiveERGfusion-positive prostate cancers

(2013) Antje Krohn et al.   JOURNAL OF PATHOLOGY

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

(2013) Martina Kluth et al.   MODERN PATHOLOGY

High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer

(2013) Yasuyoshi Miyata et al.   PLoS One

Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression

(2013) Ding-Ping Sun et al.   TUMOR BIOLOGY

Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma

(2013) Cong Zhang et al.   TUMOR BIOLOGY

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

(2012) Antje Krohn et al.   AMERICAN JOURNAL OF PATHOLOGY

Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades

(2012) Jonathan I. Epstein et al.   EUROPEAN UROLOGY

HuR posttranscriptionally regulates early growth response-1 (Egr-1) expression at the early stage of T cell activation

(2012) Zongchun Mou et al.   FEBS LETTERS

Antagonistic Function of the RNA-binding Protein HuR and miR-200b in Post-transcriptional Regulation of Vascular Endothelial Growth Factor-A Expression and Angiogenesis

(2012) Sung-Hee Chang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Radical Prostatectomy versus Observation for Localized Prostate Cancer

(2012) Timothy J. Wilt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy

(2011) Sarah Minner et al.   CLINICAL CANCER RESEARCH

A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease

(2011) Vanessa C. Thompson et al.   INTERNATIONAL JOURNAL OF CANCER

Genomic Analyses of the RNA-binding Protein Hu Antigen R (HuR) Identify a Complex Network of Target Genes and Novel Characteristics of Its Binding Sites

(2011) Philip J. Uren et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cooperative Role of the RNA-Binding Proteins Hzf and HuR in p53 Activation

(2011) H. Nakamura et al.   MOLECULAR AND CELLULAR BIOLOGY

HuR Regulates  -Tubulin Isotype Expression in Ovarian Cancer

(2010) G. Raspaglio et al.   CANCER RESEARCH

Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis

(2010) Matthew M Gubin et al.   CELL CYCLE

Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer

(2010) S. Minner et al.   CLINICAL CANCER RESEARCH

Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer

(2010) Jun Wang et al.   MEDICAL ONCOLOGY

HuR Knockdown Changes the Oncogenic Potential of Oral Cancer Cells

(2010) W. Kakuguchi et al.   MOLECULAR CANCER RESEARCH

Towards a knowledge-based Human Protein Atlas

(2010) Mathias Uhlen et al.   NATURE BIOTECHNOLOGY

ETS gene fusions in prostate cancer

(2009) Jeremy P. Clark et al.   Nature Reviews Urology

Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR

(2008) Anke Doller et al.   CELLULAR SIGNALLING

Overexpression of ELAV-like Protein HuR is Associated with Increased COX-2 Expression in Atrophy, High-grade Prostatic Intraepithelial Neoplasia, and Incidental Prostate Cancer in Cystoprostatectomies

(2008) Francesca Barbisan et al.   EUROPEAN UROLOGY

Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA-binding protein HuR

(2008) Xin Tong et al.   MOLECULAR CARCINOGENESIS

Identifizierung und Validierung klinisch relevanter molekularer Veränderungen im Prostatakarzinom

(2008) T. Schlomm et al.   UROLOGE